LRMR vs PNC · $204.9M cap vs P/E 14, rev $23.10B
Larimar Therapeutics Inc (LRMR) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
LRMR does not have a complete income-statement cache yet.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
LRMR currently screens at market cap $204.9M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the LRMR and PNC stock pages for the full models.
Not investment advice.